Panacea Biotec Limited has informed the stock exchanges regarding the dematerialization of shares for the month of January 2026. As per the communication, no shares were dematerialized during this period. The company confirmed that as of January 31, 2026, the total number of shares dematerialized stood at 6,11,01,526. This includes 5,34,32,223 shares held with NSDL and 76,69,303 shares held with CDSL. A certificate from the company's Registrar and Share Transfer Agent (RTA), Skyline Financial Services Pvt. Ltd., corroborating these figures as of January 31, 2026, has also been enclosed. This update is in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.
